CD19 and acute lymphoblastic leukemia: To perform these cytotoxicity assays, B-ALL or PDAC cells were incubated with either CD19 or control CAR T cells at an effector-to-target (E:T) ratio of 10:1 with increasing concentrations of the DFO-PEG20-CD19 probe (ranging from 0 to 100 nM).